News | September 26, 2022
NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN
NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.
NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.
The companies will leverage their respective proprietary technology platforms
Rabies claims around 59,000 deaths globally a year, of which around 20,000 or just over one-third of the deaths take place in India alone
The startup plans to provide free technology to dental clinics upon registration.
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
To set up 50 lifestyle modification centres across the UAE in the next 24 months
The country has been witnessing a progressive reduction in IMR, U5MR and NMR
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
The plant at Raleigh, North Carolina, USA owned by Aurolife Pharma has received an establishment inspection report (EIR)
Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR
Subscribe To Our Newsletter & Stay Updated
